Accelerate to discover
Related topics
Theranostics: From Mice to Men and Back
Jun 25, 2024
Recorded webinar
Presenters: Prof. Dr. Ken Herrmann and Prof. Dr. Katharina Lückerath – Moderator: Hannah Notebaert
Orion 2024 AACR poster: 17-plex single-step stain and imaging of cell Lung Carcinoma
Jun 21, 2024
RareCyte Orion is a benchtop, high resolution, whole slide multimodal imaging instrument. A combination of quantitative...
New release now available: Cytek Amnis AI v3.0 Software
Jun 17, 2024
The new Cytek Amnis AI v3.0 image analysis software features an integrated transfer learning algorithm, an option to...
Cytek webinar: Imaging Flow Cytometry for Chromosomal Assessment in Hematological Malignancies
Jun 7, 2024
In this webinar, we will describe a new innovative approach we developed that resolves these limitations. The method...
Hypoxia in the Tumor Immune Microenvironment (TIME)
Jun 6, 2024
Thursday, 11 July 2024, 16:00 CET | 10:00 EST
Zaver M. Bhujwalla, PhD
X-RAD 320 for irradiation therapy during quantifying study for in vivo collagen reorganization
Jun 5, 2024
Quantifying in vivo collagen reorganization during immunotherapy in murine melanoma with second harmonic generation...
Use of MRI and microCT to evaluate gene therapy for the treatment of discogenic back pain
Jun 4, 2024
MRI images were obtained using the 9.4T Bruker BioSpec system, equipped with 40 mm 1H quadrature volume resonator, and...
Exosome-Mediated Delivery of Small Molecules, RNA & DNA for Development of Novel Cancer Therapeutics
Jun 3, 2024
Disha Moholkar of University of Louisville's Gupta Lab
Tuesday, June 11, 2024, 6:30 PM...
Oct 21, 2022
These presentations fit nicely into a main theme of the conference: defining strategies to enhance the function of adoptive cell therapies in the suppressive solid tumor microenvironment (TME). While many researchers have proposed the use of novel genetic circuits and cytokines to address this problem, Xcellbio’s approach relies on precise control of the cell culture environment to potentiate cell function in the hypoxic, highly pressured TME. Another hot topic at the CAR-TCR conference was the need for improved characterization and potency assays that more closely mimic a cell therapy’s mechanism of action. By enabling real time cell killing assays to be performed under TME-like conditions, the AVATAR AI provides a more physiologically relevant, and likely more predictive, readout of a therapy’s in vivo efficacy.
Related technologies: Physiological cell culturing
Get more info
Brand profile
The company provides a revolutionary cell culturing platform that replicates the physiological environment of native tissues to deliver reproducible and biologically relevant molecular analysis.
More info at:
www.xcellbio.com
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
